Xiulin Yi
Impact in
- Pharmacology top 5%
- Pharmacological Effects of Natural Compounds
- Plant-based Medicinal Research
- Nephrology top 10%
- Gout, Hyperuricemia, Uric Acid
Papers in
-
- Epigenetics and DNA Methylation 2
- Oncology 10
- Drug Transport and Resistance Mechanisms 9
- Co-authors
- Qiu‐Yi Duan (1 shared paper)Fu‐Gen Wu (1 shared paper)Changxiao Liu (17 shared papers)Yazhuo Li (11 shared papers)Dexin Kong (3 shared papers)Lele Li (1 shared paper)Zhenghan Di (1 shared paper)Duanyun Si (6 shared papers)
- Journals
- Current Drug Metabolism (4 papers)Xenobiotica (2 papers)The FASEB Journal (2 papers)Journal of Nephrology (1 paper)Acta Pharmaceutica Sinica B (1 paper)
- Partner nations
- ChinaMacaoUnited Kingdom
In The Last Decade
Xiulin Yi
27 papers receiving 626 citations
Peers
Comparison fields: 5 of 86
- Pharmacology 123
- Nephrology 60
- Biomaterials 90
- Complementary and alternative medicine 50
- Biomedical Engineering 210
Countries citing papers authored by Xiulin Yi
This map shows the geographic impact of Xiulin Yi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiulin Yi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiulin Yi more than expected).
Fields of papers citing papers by Xiulin Yi
This network shows the impact of papers produced by Xiulin Yi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiulin Yi. The network helps show where Xiulin Yi may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiulin Yi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 208 | |
| 2 | 2018 | 69 | |
| 3 | 2017 | 64 | |
| 4 | 2011 | 47 | |
| 5 | 2017 | 41 | |
| 6 | 2023 | 32 | |
| 7 | 2019 | 25 | |
| 8 | 2018 | 23 | |
| 9 | 2015 | 23 | |
| 10 | 2020 | 15 | |
| 11 | 2015 | 14 | |
| 12 | 2018 | 13 | |
| 13 | 2024 | 9 | |
| 14 | 2019 | 9 | |
| 15 | 2016 | 8 | |
| 16 | 2015 | 7 | |
| 17 | 2020 | 6 | |
| 18 | 2019 | 6 | |
| 19 | 2018 | 3 | |
| 20 | 2014 | 2 |
About Xiulin Yi
Xiulin Yi is a scholar working on Molecular Biology, Oncology, Pharmacology, Surgery and Pediatrics, Perinatology and Child Health, having authored 28 papers that have together received 632 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (9 papers), Pharmacological Effects of Natural Compounds (6 papers), Pancreatic function and diabetes (5 papers), Pharmacological Effects and Toxicity Studies (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Plant-based Medicinal Research (3 papers), Diabetes Management and Research (2 papers) and Epigenetics and DNA Methylation (2 papers). The work is most often cited by research in Pharmacology (123 citations), Nephrology (60 citations), Biomaterials (90 citations), Complementary and alternative medicine (50 citations) and Biomedical Engineering (210 citations). Xiulin Yi has collaborated with scholars based in China, Macao and United Kingdom. Frequent co-authors include Qiu‐Yi Duan, Fu‐Gen Wu, Changxiao Liu, Yazhuo Li, Dexin Kong, Lele Li, Zhenghan Di, Duanyun Si, Min Gong and Cui Tao. Their work appears in journals such as Current Drug Metabolism, Xenobiotica, The FASEB Journal, Journal of Nephrology and Acta Pharmaceutica Sinica B.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.